chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diarrhea, bloody stools; RSV (Respiratory syncytial virus); milk allergy; This spontaneous report was received from a physician referring to a 6-weeks-old patient whose gender was not specified. Information about the patient's pertinent medical history, concurrent conditions, drug reactions, allergies and concomitant therapies was not provided.  On an unspecified date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ), orally, as rotavirus prevention (dose, vaccination scheme frequency, lot number and expiration date were not reported).  On unspecified subsequent dates, the patient experienced diarrhea, bloody stools (haematochezia) and developed respiratory synctial virus (RSV). The patient sought for medical care and was hospitalized (inconsistent information, as it was also reported being unknown if the patient was already hospitalized and a prolonged hospitalization occurred after rotavirus vaccine, live, oral, pentavalent (ROTATEQ) use) and after unspecified tests were performed was diagnosed with a milk allergy. The patient received an unspecified treatment.  The event of haematochezia resolved on an unspecified time, by the time of reporting the physician stated that next dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) had been given to the patient and the patient had not had any gastrointestinal symptoms. Besides, since the patient's diagnose had been made the outcome of respiratory syncytial virus infection and milk allergy were reported as resolving. The causal relationship between the administered vaccine and the occured events was not provided by the reporter.  Upon internal review, the event haematochezia was determined to be medically significant.
Began severe chills and fever of unknown temperature 12 hours (10PM) after injection, severe joint and skeletal pain did not respond to ibuprofen. Mild headache began around 5AM. Symptoms resolved by 10 AM  04/22/2021.
achy; feeling down; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy), DEPRESSED MOOD (feeling down) and PYREXIA (fever) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included Nausea, Pain, Fever and .    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced MYALGIA (achy), DEPRESSED MOOD (feeling down) and PYREXIA (fever). At the time of the report, MYALGIA (achy), DEPRESSED MOOD (feeling down) and PYREXIA (fever) outcome was unknown.            This case was linked to US-MODERNATX, INC.-MOD-2021-080215 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080215:2nd dose events
Patient had second covid 19 vaccine on 2/2/21 at pharmacy. Was admitted on 4/6/21 to hospital with Shortness and Breath, Vomiting, and COVID-19 (tested positive on 4/6/21). Patient expired on 4/8/21 @ 1954.
Body ache; Headache; This spontaneous case was reported by a pharmacist and describes the occurrence of MYALGIA (Body ache) and HEADACHE (Headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced MYALGIA (Body ache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, MYALGIA (Body ache) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.    This case was linked to MOD-2021-068385 (Patient Link).
Bruise at injection site, entire arm red & swollen. Still swollen (red going away).
Patient vaccinated in Jan/Feb and in August 2021, patient started to develop episodes of dizziness possibly being othostatic hypotension. This was accompanied by tachycardia, with HR noted to be 120 during urgent care visit and an appt was scheduled with her PCP. Toward the end of the month, around 8/27/21, patient developed upper respiratory symptoms manifesting as cough, tiredness, and shortness of breath. Arrived to walk in clinic for COVID screening and found Positive PCR result from test 8/30/21. Patient was referred for monoclonal antibody therapy leading to infusion on 9/1/21 of REGEN-COV. This is reported on 9/1/21 and no future information is known at this time.
Pt. tested positive for COVID 3/16/21. Completed COVID vaccine series 1/18/21. Asymptomatic. Tested for  prevalence test.
INCORRECT PRODUCT STORAGE; OUT OF SPECIFICATION PRODUCT USE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced incorrect product storage, and out of specification product use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the incorrect product storage and out of specification product use was not reported. This report was non-serious.
This is a 89y.o. female that presented whom  has a past medical history of Activity extremely limited, Arthritis, Blood transfusion, Bradycardia with 41 - 50 beats per minute, Cancer (4/2013), Diabetes mellitus (CMS/HCC) (AGE 62), Exercise habits, History of EKG, Hyperlipidemia, Hypertension (4/2013), Osteoporosis, Pacemaker (5/5/15), SSS (sick sinus syndrome) (5/10/2015), and Thyroid disease. and was admitted to hospital on 10/6/2021 for dizziness and weakness. She was found to have A-fib with RVR, and she also has DKA. Fluids bolus was started and insulin therapy. Patient was also placed on Abx for possible UTI. Patient denies Fever, chills, SOB, or chest pain. Physical medicine and rehabilitation team was consulted to evaluate for rehabilitation needs. The patient appears to be well below baseline for ADLs and IADLs and requiring assistance with mobility and transfers. Admitted on 10/13/21.
Patient was diagnosed with COVID-19 after being fully vaccinated - asymptomatic preoperative testing.
Urticaria/hives covering trunk and arm; legs and buttock. MEDROL DOSE PACK and LORATADINE 10 mg RtC 2 weeks
Shortly after being administered the vaccine (within 5 minutes), patient had passed out in the lobby and fell and hit his head.  He was taking back to the exam room and assessed by the provider.  Patient was pale, clammy, and appeared dazed.  He was able to answer simple questions when asked.  Once symptoms improved and were resolved, patient was able to walk out of the office without assistance.
Local swelling and induration with some tingling down (R) arm within (6) several hours of vaccination. Onset nausea and vomiting with diarrhea also last evening (3/4/15).
Hives, wheals all over the lower torso after both injections. Extreme fatigue, headache, and fever for 3-4 days with both injections. took about 4 weeks for fatigue to dissipate. Hives treated with Benedryl lasted about a week, would ease up then flare up again.
Moderate fever (102F); chills; congestion (sinus/chest); muscle aches; malaise; cough; sore throat - identical to influenza symptoms, lasting 9 days.  NOTE: Not every dose of vaccine can be QC tested for complete inactivation - which is my friggin' concern here.
1420  Patient received 1st dose of Pfizer Covid1-9 Vaccine. Patient ambulated to Observation  Area.   1435  Patient alerted RN regarding difficulty swallowing  and throat  Tightness. Patient was taken to the observation via wheelchair. DR At bedside. Patient was offered water and it was well tolerated. Dr assesment was completed   1440  BP 129/89 HR 77 RR 20 SpO2 100% RA After Dr re- assessment was completed, he noticed worsening  throat swelling.  EPI ordered by MD.  Charge RN informed. 911 Called . No Stridor, no Respiratory distress. Continuous Pulse oxymetry in place.   1442   Epi 0.3 mg ( Left upper leg  ( by RN )  , Zyrtec 10 mg PO and Benadryl 25 mg PO given.   1450   BP 134/88 HR 74 RR 20 SpO2 100% RA    1451 Patient taken to Building 6 Via wheelchair. Patient able to speak at this time. MD at the bedside.    1455  Fire rescue arrived. Report given. Patient stable. Patient being transported to Emergency room.  BP 150/96 HR 88 RR 20 SpO2 100 % RA
Patient received Pfizer 5-11 y/o dose instead of adult dose.  Pediatric vial was diluted as if it were the adult vial and 0.3ml was administered.
After first shot on March 17th, around April 1st began having Diarrhea 2-4 times a day and after 2nd dose increased to 4-5.    After 2nd dose when I woke up the following morning Tinnitus began in my ears and has not stopped for two straight days.
no adverse effects; The patient was inadvertently administered an expired dose of Rotateq; This spontaneous non valid report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided.     On 16-OCT-2019, the patient was inadvertently vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) lot # R007150, expiration date on 15-OCT-2019, orally, for prophylaxis(strength, dosage and frequency were not provided) (expired product administered). No adverse effects were reported. There were no temperature excursion.
pt recv vax & w/in 1wk pt devel a low grade fever - 99-101, nausea & was not feeling self;pt vomited twice;pt appeared somewhat clumsy;dx viral infect;pt found unable to get up or walk;no deep tendon reflex, speech slurred Dx=encephalitis  Annual follow-up received on 11/27/00 provided no additional data.
Mom describes large area of redness from site up near shoulder and above elbow redness does not extend to past elbow. Warm to touch.
Patient suffered anaphylaxis after receiving TDAP and PNEUMOVAX at primary MD's office. (Patient known to me for cow milk allergy with hx of anaphylaxis). Strongly + puncture skin tests subsequently with TDAP and cow milk. Negative PNEUMOVAX ST.
Lightheaded and dizzy; arm was burning and sore; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheaded and dizzy) and VACCINATION SITE PAIN (arm was burning and sore) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Lightheaded and dizzy) and VACCINATION SITE PAIN (arm was burning and sore). On 15-Jan-2021, DIZZINESS (Lightheaded and dizzy) had resolved. At the time of the report, VACCINATION SITE PAIN (arm was burning and sore) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Patient reports feeling symptoms later the same evening the day of receiving her 2nd dose of Moderna.  Her twin sister, also reported similar symptoms after receiving her 2nd dose of Moderna the same day (3/5/21).  Patient reported feeling nausea and having "extreme" chills that evening.  The next morning at 8 a.m. Patient called her sister, at 8 a.m. When she arrived at her sister's house she found patient unresponsive.  She was taken to the hospital and remained there for 5 hours.   Patient reports passing out, losing control of her bodily functions and hitting her head on a heavy resin figure.  "Blood was all over the place."  She reports that 2 spots on her scalp were bleeding and subsequently treated at the hospital.   Patient currently is still experiencing extreme fatigue following the vaccination.
Stomach cramps; arm soreness; severe vertigo; nausea; unable to get up or walk; dizziness; Dose Number 2, Date of start of drug 21Jan2021/ Dose Number 1, Date of start of drug 29Dec2020; This is a spontaneous report from a contactable nurse (patient). A 51-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL3249, expiration date: unknown), via an unspecified route of administration on the left arm on 21Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has no allergies to medications, food, or other products. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284, expiration date: unknown) in the left arm on 29Dec2020 at 15:00 (3:00PM) for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 23Jan2021 at 04:00, the patient experienced stomach cramps and arm soreness for two days. On the same day, the patient experienced severe vertigo with nausea and was unable to get up or walk. The following day, 24Jan2021, vertigo was slightly less. On the fifth day, the patient was still having some dizziness and nausea. No treatment was administered for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The events stomach cramps and arm soreness resolved in 25Jan2021, and the events nausea, unable to get up or walk and dizziness had not resolved, while the event severe vertigo was resolving.
The white part of my eye has turned red. The intensity of red varies. The veins are NOT showing like typical blood shot eyes. My General Practitioner knows about it and has no given me advice other than to see the eye specialist. The Eye Specialist did not solve it. They tried different glaucoma eye drops nothing worked.  The eye drop Lumify give some and varying amount of comfort
Headache, Aches and Pains, Sore Throat, Cough, nausea and Chills.
This spontaneous report as received from a consumer son refers to a 85 year old male patient with none drug reactions or allergies or patient medical history. On 03-APR-2013 the patient was vaccinated with a standard dose (0.5 mL) of PNEUMOVAX 23 (lot # H014561, expiration date 21-MAR-2014 (route not specified). There were no concomitant medication. The patient's son explained that his father after received the dose of PNEUMOVAX 23 on 05-APR-2013, developed pain and redness at the injection site followed by an overall feeling of malaise. The patient's son explained that on 05-APR-2013 the patient's urine turned dark amber color and he developed severe abdominal pain. The patient then developed chest pains and continued to have dark urine through 07-APR-2013 and went to his local urgent care for treatment. At the urgent care facility a liver bilirubin test showed level 8. The patient began to show signs of jaundice on the 09-APR-2013 and was admitted to the hospital. The patient was discharged on 12-APR-2013 when the chest pain went away. The patient followed up with his primary care physician where a blood test showed his bilirubin levels had gone up to 14. Additional test were ordered and the patient continued to have dark amber urine and jaundice symptoms including yellow-itchy skin. The blood test results ordered from the follow up visit were received on 25-APR-2013 and showed bilirubin level of 21-22. The patient was hospitalized again on 26-APR-2013 and was still admitted for treatment of the event. The patient's son explained that bilirubin levels have maintained at 21-22 currently and he was still experiencing Jaundice symptoms. The patient has had a biopsy conducted on Monday morning and an magnetic resonance (MRI) prior to the biopsy and was awaiting those results. The patient's treating physician believes that the reaction was drug induced. It was reported that the patient did not receive treatment for his experience. The outcome of jaundice, developed severe abdominal pain, urine turned a dark amber color, overall feeling of malaise and pain and redness at the injection site was reported as not recovered/not resolved. Additional information has been requested.
SEVERE PAIN IN ARM; SWELLING; ITCHING AT INJECTION POINT; FATIGUE; LOST OF APPETITE.
Severs Red Swelling in the left arm area of the injection site and below. Rash on both arms and upper body. Fever, slight headache. Dr at Urgent Care prescribed Cephalexin 500 MG Capsules for 10 days  Cellulitis diagnosis.
Patient states he felt some numbness and tingling in my 3rd and 4th digits in lower left arm along ulna nerve.  States he is experiencing mononeuritis of the ulna nerve.
it's like cellulitis; swollen and it feels warm to the touch; swollen and it feels warm to the touch; It's red; feels like a slight fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE CELLULITIS (it's like cellulitis), VACCINATION SITE WARMTH (swollen and it feels warm to the touch), VACCINATION SITE SWELLING (swollen and it feels warm to the touch), VACCINATION SITE ERYTHEMA (It's red) and PYREXIA (feels like a slight fever) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included Cellulitis.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE CELLULITIS (it's like cellulitis), VACCINATION SITE WARMTH (swollen and it feels warm to the touch), VACCINATION SITE SWELLING (swollen and it feels warm to the touch), VACCINATION SITE ERYTHEMA (It's red) and PYREXIA (feels like a slight fever). At the time of the report, VACCINATION SITE CELLULITIS (it's like cellulitis), VACCINATION SITE WARMTH (swollen and it feels warm to the touch), VACCINATION SITE SWELLING (swollen and it feels warm to the touch), VACCINATION SITE ERYTHEMA (It's red) and PYREXIA (feels like a slight fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 36.2 degree Celsius (Inconclusive) 36.2C.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Tylenol used as a Treatment Medication. No concomitant Medication was Provided.
Day 1: Fatigue, Arm Sore/ Swollen, Feeling unwell, Raised temp 99.3, Brain Fog, Puffy Cheeks, Day 2: Arm so sore I could not lift above my head, Fatigue,Headache, Day 3: Severe Lower Back Pain, Arm soreness subsided, Day 4: Severe Lower Back Pain, Hip Pain, Knee Pain, Day 5: Severe Lower Back Pain, Hip Pain, No appetite Day 6: Injection Site and Surrounding Area Swollen/Itchy/Sore/Raised Rash, Chills, Fatigue, Waves of Nausea, No appetite< No fever> Day 7: Chills, Exhaustion, Arm is Same as Day 6, Brain Fog, Raised Temp 99.4
She experienced difficulty breathing on an unspecified date.; She became anxious.; She became irritable.; She became depressed.; She became shaky.; She was tired.; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (She experienced difficulty breathing on an unspecified date.), ANXIETY (She became anxious.), IRRITABILITY (She became irritable.), DEPRESSION (She became depressed.) and TREMOR (She became shaky.) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant past medical history was provided.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), LISINOPRIL and CALCIUM for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced FATIGUE (She was tired.). On 29-Mar-2021, the patient experienced ANXIETY (She became anxious.), IRRITABILITY (She became irritable.), DEPRESSION (She became depressed.) and TREMOR (She became shaky.). On 06-Apr-2021, the patient experienced DYSPNOEA (She experienced difficulty breathing on an unspecified date.). At the time of the report, DYSPNOEA (She experienced difficulty breathing on an unspecified date.), ANXIETY (She became anxious.), IRRITABILITY (She became irritable.), DEPRESSION (She became depressed.), TREMOR (She became shaky.) and FATIGUE (She was tired.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included buspirone. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), LISINOPRIL and CALCIUM for an unknown indication   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Telephone contact report- patient not willing to provide mail id or fax number
Flu mist administered 10/27/2008.  Called stating that she had body aches, severe head ache, dizziness and nasal congestion.  She was told that she was having a response to the flu vaccine and would feel better in a few days.  She came into the office again today 11/6/2008 stating she is still having symptoms of head ache, dizziness, body aches and now jitteriness and rapid heart rate.